913611-97-9 依匹哌唑

依匹哌唑

英文名称:Brexpiprazole
CAS:

913611-97-9

分子式:C25H27N3O2S
精选商品
  • 化合物简介
  • 基本信息
  • 编号系统
  • MSDS
  • 图谱

依匹哌唑简介

Brexpiprazole (brand name Rexulti recks-UL-tee, previously known as OPC-34712) is a novel atypical antipsychotic drug. It is a D2 dopamine partial agonist called serotonin-dopamine activity modulator (SDAM). The drug received FDA approval on July 13, 2015 for the treatment of schizophrenia, and as an adjunctive treatment for depression. Although it failed Phase II clinical trials for ADHD, it has been designed to provide improved efficacy and tolerability (e.g., less akathisia, restlessness and/or insomnia) over established adjunctive treatments for major depressive disorder (MDD).
The drug was developed by Otsuka and Lundbeck, and is considered to be a successor of Otsuka's top-selling antipsychotic agent aripiprazole (brand names: Abilify, Aripiprex). Otsuka's US patent on aripiprazole expired on October 20, 2014; however, due to a pediatric extension, a generic will become available in the near future.

依匹哌唑基本信息

中文名称 依匹哌唑 英文名称 Brexpiprazole
中文别名

7-(4-(4-(苯并[B]噻吩-4-基-哌嗪-1-基)丁氧基)-1H-喹啉-2-酮; 布雷帕唑; [依匹唑派];

查看更多中文别名
英文别名

OPC-34712; 7-[4-(4-benzo[b]thien-4-yl-1-piperazinyl)butoxy]- 2(1H)-Quinolinone; 7-[4-[4-(1-Benzothiophen-4-yl)piperazin-1-yl]butoxy]-1H-quinolin-2-one; 7-(4-(4-(Benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)quinolin-2(1H)-one; Rexulti; 7-[4-(4-(Benzo[b]thien-4-yl)-piperazin-1-yl)butoxy]-1H-quinolin-2-one;

查看更多英文别名
CAS号 913611-97-9 分子式 C25H27N3O2S
分子量 433.56600 精确质量 433.18200
PSA 77.07000 LOGP 5.13920

依匹哌唑编号系统

MDL号 MFCD27987920
SDS 1.0 中文 展开
SDS 1.0 英文 展开
1H NMR : Predict展开

核磁图谱 1H NMR : Predict

收起
查看更多
依匹哌唑
CAS号:913611-97-9 分子式:C25H27N3O2S 分子量:433.56600

化工圈APP

二维码

微信公众号

二维码

购物车

不要让您的购物车空着哦,买试剂买原料
如果您已添加过宝贝,那就赶紧登录查看吧

投诉建议

  • 咨询类别
  • 问题描述
  • 联系人电话
  • 联系人